The Patent Finder

Terms ending in 2037

Adimab, LLC

Every in-force patent on Adimab, LLC's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,053,515Anti-Coagulation Factor XI Antibodies
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 10,584,179Anti-Coagulation Factor XI Antibodies
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 12,180,299Multispecific Antibody Analogs Comprising a Common Light Chain, and Methods of Their Preparation and Use
In force
 · High confidence
Adimab, LLCIn forceHigh confidence
US 10,307,455Activin Type 2 Receptor Antibodies
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 11,000,565Methods of Increasing Muscle Mass by Administration of Activin Type 2 Receptor Antibodies
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 10,689,450Bcma Binding Molecules and Methods of Use Thereof
In force
 · High confidence
Kite Pharma, Inc.In forceHigh confidence
US 11,059,894ALK7 Binding Proteins and Uses Thereof
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 11,981,738ALK7 Binding Proteins and Methods of Reducing ALK7 Activity Using the Same
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 10,501,547ALK7 Binding Proteins and Uses Thereof
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 10,684,289Polyclonal Mixtures of Antibodies, and Methods of Making and Using Them
In force
 · High confidence
Adimab, LLCIn forceHigh confidence
5 more term ends in 2037 · Pro
10 of 15 patents shown. Soonest term end first, then patent number.
Pro members see all 15.
Upgrade to Pro
5 of these are in force and held by Adimab, LLC.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited